|Chemical name: Sacubitril/Valsartan
Typical dosage: 24mg
Typical type: Tablet1
Entresto® is a medication typically used to treat heart failure. It is a brand name only medication and is available as an oral tablet.
Entresto is a prescription medication that contains the active ingredients Sacubitril and Valsartan.
Entresto is taken twice daily and the dose is usually increased after 2-4 weeks as tolerated. Entresto relaxes blood vessels so that blood can flow more easily, which makes it easier for the heart to pump blood to the body.
The most common side effects of Entresto include low blood pressure, increased potassium, and a dry cough.
Yes! 100% of Medicare Advantage plans and Medicare Part D plans cover Entresto.1
Drug coverage may vary based on plan availability. You may be able to find Medicare Advantage plan options in your area that cover Entresto.
Find Medicare Advantage plans with drug coverageCompare Plans
Or call TTY Users: 711 24/7 to speak with a licensed insurance agent.
Your copay and deductible costs for any prescription drug can vary depending on what coverage stage you’re in.
|Deductible stage||Typical copay stage|
|Your deductible is the amount of money you must spend on covered drugs before your Medicare drug coverage starts paying its share of costs.
In the deductible stage, you’re responsible for the full cost of your prescription drugs.
Some Medicare prescription drug plans have a $0 deductible. Medicare drug plans cannot have a deductible more than $415 in 2019.
|After you meet your Part D deductible, you enter the initial coverage period.
During this phase (the typical copay stage), you pay a copayment (flat fee) or coinsurance (percentage) for your covered medications.
|$42 – $573||$19 – $550|
You may not be able to feel the effects of Entresto. Do not stop taking this medicine unless instructed by your doctor.
Low blood pressure can occur with Entresto. Call your doctor if you feel dizzy, weak, or feel like passing out.
Call your doctor if you experience signs of kidney problems including inability to pass urine, change in how much urine is passed, blood in the urine or weight gain.
You should also call your doctor if you have signs of high potassium levels including an abnormal heart beat; change in thinking clearly and with logic; feeling weak, lightheaded or dizzy; feeling like passing out; numbness, tingling or shortness of breath.
Entresto may be combined with other medications to adequately control your heart failure. Entresto should not be used with ACE-inhibitors such as losartan, valsartan or Irbesartan. You may have to delay starting Entresto if you have recently been taking an ACE-inhibitor.
This article is for informational purposes only. It is not healthcare advice, treatment, or diagnosis. It is not an endorsement of or recommendation for this medication. Speak to your doctor or healthcare provider about your specific healthcare needs, including your prescription medications. Only take medication as directed by your doctor.
Coverage and costs of prescription medications will vary by Medicare plan. Not all plans are available in all areas.
Join our Medicare Advantage email series.
By clicking "Join now" you are agreeing to receive emails from MedicareAdvantage.com
Copyright © 2019 TZ Insurance Solutions LLC. All rights reserved.
1 GoodRx. Entresto. Retrieved May 2019, from www.goodrx.com/entresto.
2 Jacobson, Gretchen; et al. A Dozen Facts About Medicare Advantage. (Nov. 13, 2018). Kaiser Family Foundation. Retrieved from www.kff.org/medicare/issue-brief/a-dozen-facts-about-medicare-advantage.
MedicareAdvantage.com is a website owned and operated by TZ Insurance Solutions LLC. TZ Insurance Solutions LLC and TruBridge, Inc. represent Medicare Advantage Organizations and Prescription Drug Plans having Medicare contracts; enrollment in any plan depends upon contract renewal.
Plan availability varies by region and state. For a complete list of available plans, please contact 1-800-MEDICARE (TTY users should call 1-877-486-2048), 24 hours a day/7 days a week or consult www.medicare.gov.
Medicare has neither reviewed nor endorsed this information.